The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
about
Progress of small molecular inhibitors in the development of anti-influenza virus agents.Iminosugars: Promising therapeutics for influenza infection.N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes.The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit.Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses.Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.Molecular Markers for Interspecies Transmission of Avian Influenza Viruses in Mammalian Hosts.The emerging influenza virus threat: status and new prospects for its therapy and control.Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution.Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance.Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.Nucleosides for the treatment of respiratory RNA virus infections.K63-Linked Polyubiquitination on TRAF6 Regulates LPS-Mediated MAPK Activation, Cytokine Production, and Bacterial Clearance in Toll-Like Receptor 7/8 Primed Murine Macrophages.Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.The mechanism of resistance to favipiravir in influenza
P2860
Q30234943-4E90C9EE-6AB1-4CE7-8F07-227D2E049F67Q33795341-704059ED-29A0-4649-B6CA-90FF6CF4563AQ37166751-0A55667C-DEEF-4990-951D-BF193822D89EQ38963385-D6326AD0-F56C-4D43-B47F-B2F8FD20583BQ40071053-B26ADEAC-9BD3-4B11-B6E3-040FBE3FDB17Q40251943-A995E03F-F8B6-4D09-840D-6740CD30BB15Q40559394-A4BDCC5D-3032-4F10-A172-E069D45AAC32Q46242252-56ED6020-966B-4F87-A1E5-FE5399AC95D9Q47555634-4D6323F3-3411-4751-BAAF-2571C442711EQ47569878-0B904231-A357-4153-ADC3-A983EDF8516EQ49358466-E1DF64AB-B10F-4F7E-A6F9-4AF515710E37Q50034148-6B2A995F-024E-476C-9F51-54C445A73248Q51783651-94CD7402-6063-4F80-91EE-2BDFD0F678C1Q52565527-4EA769A9-58CC-49CD-AD4D-457368AACE86Q52644426-8CB3761F-9657-48D6-AC93-68DBA0CA29C4Q52668324-F22F0747-CE33-4DEF-BA0C-62D0A7D049B4Q55426854-65C60417-1360-49B1-A258-00C68900CA2DQ55447639-D42A0DBC-5711-4717-8ACE-21E307842266Q57799444-5D64788A-09B3-4066-83AC-E0A52F68D0EE
P2860
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@ast
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@en
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@nl
type
label
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@ast
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@en
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@nl
prefLabel
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@ast
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@en
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@nl
P2860
P921
P3181
P356
P1476
The Influenza Virus Polymerase ...... ance for Antiviral Drug Design
@en
P2093
Annelies Stevaert
P2860
P304
P3181
P356
10.1002/MED.21401
P407
P577
2016-08-29T00:00:00Z